286 related articles for article (PubMed ID: 36442853)
21. Detection of Major SARS-CoV-2 Variants of Concern in Clinical Samples via CRISPR-Cas12a-Mediated Mutation-Specific Assay.
Liang Y; Zou L; Lin H; Li B; Zhao J; Wang H; Sun J; Chen J; Mo Y; Yang X; Deng X; Tang S
ACS Synth Biol; 2022 May; 11(5):1811-1823. PubMed ID: 35481381
[No Abstract] [Full Text] [Related]
22. Detection of the SARS-CoV-2 D614G mutation using engineered Cas12a guide RNA.
Meng Q; Wang X; Wang Y; Dang L; Liu X; Ma X; Chi T; Wang X; Zhao Q; Yang G; Liu M; Huang X; Ma P
Biotechnol J; 2021 Jun; 16(6):e2100040. PubMed ID: 33595922
[TBL] [Abstract][Full Text] [Related]
23. Integrating CRISPR-Cas12a with a crRNA-Mediated Catalytic Network for the Development of a Modular and Sensitive Aptasensor.
Shu X; Zhang D; Li X; Zheng Q; Cai X; Ding S; Yan Y
ACS Synth Biol; 2022 Aug; 11(8):2829-2836. PubMed ID: 35946354
[TBL] [Abstract][Full Text] [Related]
24. Rapid SARS-CoV-2 Variants Enzymatic Detection (SAVED) by CRISPR-Cas12a.
Yang J; Barua N; Rahman MN; Li C; Lo N; Yeong KY; Tsang TF; Yang X; Cheung YY; Tsang AKL; Chan RCW; Leung EC; Chan PKS; Ip M
Microbiol Spectr; 2022 Dec; 10(6):e0326022. PubMed ID: 36342324
[TBL] [Abstract][Full Text] [Related]
25. Photocontrolled crRNA activation enables robust CRISPR-Cas12a diagnostics.
Hu M; Qiu Z; Bi Z; Tian T; Jiang Y; Zhou X
Proc Natl Acad Sci U S A; 2022 Jun; 119(26):e2202034119. PubMed ID: 35727982
[TBL] [Abstract][Full Text] [Related]
26. Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimens.
Nimsamer P; Mayuramart O; Rattanaburi S; Chantaravisoot N; Saengchoowong S; Puenpa J; Poovorawan Y; Payungporn S
J Virol Methods; 2021 Apr; 290():114092. PubMed ID: 33539846
[TBL] [Abstract][Full Text] [Related]
27. AND Logic-Gate-Based CRISPR/Cas12a Biosensing Platform for the Sensitive Colorimetric Detection of Dual miRNAs.
Gong S; Wang X; Zhou P; Pan W; Li N; Tang B
Anal Chem; 2022 Nov; 94(45):15839-15846. PubMed ID: 36318504
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas based virus detection: Recent advances and perspectives.
Yin L; Man S; Ye S; Liu G; Ma L
Biosens Bioelectron; 2021 Dec; 193():113541. PubMed ID: 34418634
[TBL] [Abstract][Full Text] [Related]
29. CRISPR/Cas12a Multiplex Genome Editing of Saccharomyces cerevisiae and the Creation of Yeast Pixel Art.
Ciurkot K; Vonk B; Gorochowski TE; Roubos JA; Verwaal R
J Vis Exp; 2019 May; (147):. PubMed ID: 31205318
[TBL] [Abstract][Full Text] [Related]
30. PrimedSherlock: a tool for rapid design of highly specific CRISPR-Cas12 crRNAs.
Mann JG; Pitts RJ
BMC Bioinformatics; 2022 Oct; 23(1):428. PubMed ID: 36241974
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas12a-Assisted isothermal amplification for rapid and specific diagnosis of respiratory virus on an microfluidic platform.
Shen J; Chen Z; Xie R; Li J; Liu C; He Y; Ma X; Yang H; Xie Z
Biosens Bioelectron; 2023 Oct; 237():115523. PubMed ID: 37451024
[TBL] [Abstract][Full Text] [Related]
32. Reverse Transcription Recombinase Polymerase Amplification Coupled with CRISPR-Cas12a for Facile and Highly Sensitive Colorimetric SARS-CoV-2 Detection.
Zhang WS; Pan J; Li F; Zhu M; Xu M; Zhu H; Yu Y; Su G
Anal Chem; 2021 Mar; 93(8):4126-4133. PubMed ID: 33570401
[TBL] [Abstract][Full Text] [Related]
33. Harnessing Multiplex crRNA in the CRISPR/Cas12a System Enables an Amplification-Free DNA Diagnostic Platform for ASFV Detection.
Zeng M; Ke Y; Zhuang Z; Qin C; Li LY; Sheng G; Li Z; Meng H; Ding X
Anal Chem; 2022 Aug; 94(30):10805-10812. PubMed ID: 35857897
[TBL] [Abstract][Full Text] [Related]
34. Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.
Chen FE; Lee PW; Trick AY; Park JS; Chen L; Shah K; Mostafa H; Carroll KC; Hsieh K; Wang TH
Biosens Bioelectron; 2021 Oct; 190():113390. PubMed ID: 34171821
[TBL] [Abstract][Full Text] [Related]
35. A one-step platform for screening high-efficient and minimal off-target CRISPR/Cas13 crRNAs to eradicate SARS-CoV-2 virus for treatment of COVID-19 patients.
Li PY; Li SQ; Gao SG; Dong DY
Med Hypotheses; 2022 Feb; 159():110754. PubMed ID: 35002020
[TBL] [Abstract][Full Text] [Related]
36. Rational Programming of Cas12a for Early-Stage Detection of COVID-19 by Lateral Flow Assay and Portable Real-Time Fluorescence Readout Facilities.
Yi Z; de Dieu Habimana J; Mukama O; Li Z; Odiwuor N; Jing H; Nie C; Hu M; Lin Z; Wei H; Zeng L
Biosensors (Basel); 2021 Dec; 12(1):. PubMed ID: 35049639
[TBL] [Abstract][Full Text] [Related]
37. CRISPR-Cas12a-Based Detection for the Major SARS-CoV-2 Variants of Concern.
Liang Y; Lin H; Zou L; Zhao J; Li B; Wang H; Lu J; Sun J; Yang X; Deng X; Tang S
Microbiol Spectr; 2021 Dec; 9(3):e0101721. PubMed ID: 34787487
[TBL] [Abstract][Full Text] [Related]
38. Pre-Folded G-Quadruplex as a Tunable Reporter to Facilitate CRISPR/Cas12a-Based Visual Nucleic Acid Diagnosis.
Yang T; Li J; Zhang D; Cheng X; Li J; Huang X; Ding S; Tang BZ; Cheng W
ACS Sens; 2022 Dec; 7(12):3710-3719. PubMed ID: 36399094
[TBL] [Abstract][Full Text] [Related]
39. CRISPR-Cas12a System for Biosensing and Gene Regulation.
Shi Y; Fu X; Yin Y; Peng F; Yin X; Ke G; Zhang X
Chem Asian J; 2021 Apr; 16(8):857-867. PubMed ID: 33638271
[TBL] [Abstract][Full Text] [Related]
40. Rapid, Ultrasensitive, and Highly Specific Diagnosis of COVID-19 by CRISPR-Based Detection.
Zhu X; Wang X; Li S; Luo W; Zhang X; Wang C; Chen Q; Yu S; Tai J; Wang Y
ACS Sens; 2021 Mar; 6(3):881-888. PubMed ID: 33645226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
